Two New Plays
Add ATI and LMT Calls
Dear Bottarelli Research Member,
Two of my favorite S&P 500 components are each triggering bullish reactions to their 50-day moving averages today — and I’d like to establish new longer-dated call positions in each one.
The first stock is Allegheny Technologies (ATI — NYSE). As I’ve mentioned many times before, ATI is the largest player in the booming titanium market — and the stock has used the recent market down-turn to establish strong support at its 50-day moving average. This could set up another run at a new 52-week high, and I’d like to be positioned to capitalize on this run over the next 2 months. We could be looking at a quick $5 to $10 up-move, so let’s get positioned now.

PLAY: Buy the ATI April 110 calls (ATI DX) at or under $3.50, good for the day. Current bid/ask spread is $3.20 to $3.50. Place a protective stop loss at $1.90.
The second stock is Lockheed Martin (LMT – NYSE). Similar to ATI, LMT has just traded lower alongside the rest of the markets — but has now bounced hard off the 50-day moving average. This bounce sets up another upside run that could easily break $102.50 in the coming days, and I’d like to be positioned to profit off this upside move.

PLAY: Buy the LMT June 100 Calls (LMT FT) at or under $4.10, good for the day. Current bid/ask spread is $3.80 to $4.00. Place a protective stop loss at $2.30.
In other positioning news, our NDAQ June 30 Calls (NDQ FF) are slightly lower — but I still consider them a strong hold at current levels. Our MRO April 95 Puts (MRO PS) are right at our entry-point as MRO is currently using oil’s $1.00 down-move to threaten a stronger break to the downside. And our ITMN April 20 Puts (IQY PD) are drifting lower due to the stock’s inability to move up or down in recent days — but I still feel that the stock should be nowhere close to $22 per share. Based on their pipeline, cash position, and clinical trial results, $10 a share is more appropriate.
Lock and load!
Sincerely,

© 2012 CSR Group, LLC. All rights reserved. Published in USA.
Information, opinion, research, and commentary contained herein is obtained from sources believed to be reliable; their reliability, however, cannot be guaranteed. The maxim of Caveat Emptor applies — let the buyer beware. Bottarelli Research does not provide individual investment advice, act as an investment advisor, or individually advocate the purchase or sale of any security or investment.
Investments recommended in this service should be made only after consulting with your investment advisor, and only after reviewing the prospectus or financial statements of the company. Bottarelli Research reserves the right to use e-mail endorsements and/or profit claims from its subscribers for marketing purposes. All names will be kept anonymous and only subscriber’s initials will be used unless express written permission has been granted to the contrary.
CSR Group, LLC expressly forbids its writers from having a financial interest in any security recommended to readers. Furthermore, all employees and agents of CSR Group, LLC and its affiliate companies must wait 24 hours before following a published recommendation.
Bottarelli Research alerts contain time-sensitive information, and are published and distributed to members with urgency. Because of this, not all published materials can be adequately proofread, and an occasional spelling or grammar error may exist.
A Warning
A Wild, Wild Ride
Another Important Impact
Kick Off the Week With Profits
Lots of Bark, Little Bite
The Beat Goes On
VLO Popping – Take Profits!
Do I Trust It? No. Will We Profit Off It? Yes.
NDAQ Correction
Here Comes the Fall
Take AMX Profits!
Take AMX Profits, Part II
Take AIG Profits!
Two New Plays
A Turn for the Worst
Take LEH Profits
Take LEH Profits, Part II
Addressing the Volatility
Timing the Volatility
Not Out of the Woods Yet
Addressing the “Spillover Effect”
Picking on the Laggards
Take QCOM & WY Profits
Take KBH Profits
Watching the Fed
Add FDX Calls
Adding Downside Exposure
A Muted Friday
Time to Act
Another Put Opportunity
The Critical Next Test
Your Wednesday Update
Unable to Hold
The Best Month of the Year



